Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101

1.

Biotin for diabetic peripheral neuropathy.

Koutsikos D, Agroyannis B, Tzanatos-Exarchou H.

Biomed Pharmacother. 1990;44(10):511-4.

PMID:
2085665
2.
3.

[Influence of metabolic control on peripheral diabetic neuropathy (author's transl)].

Conte-Devolx B, Papy JJ, Conte-Devolx J, Rossi D, Fontaine G, Codaccioni JL.

Nouv Presse Med. 1981 Oct 31;10(39):3221-3. French.

PMID:
7029456
4.

The influence of pyridoxine in diabetic peripheral neuropathy.

Levin ER, Hanscom TA, Fisher M, Lauvstad WA, Lui A, Ryan A, Glockner D, Levin SR.

Diabetes Care. 1981 Nov-Dec;4(6):606-9.

PMID:
6751736
5.
6.

Three-year inhibition of aldose reductase on development of symptomatic neuropathy in diabetic patients.

Baba M, Kimura K, Suda T, Yagihashi S; Aomori Diabetic Study (ADNS) Group.

J Peripher Nerv Syst. 2006 Jun;11(2):176-8. No abstract available.

PMID:
16787519
7.

Childhood diabetic neuropathy: a clinical and electrophysiological study.

el Bahri-Ben Mrad F, Gouider R, Fredj M, Ben Becher S, Mrad-Mazigh S, Mrabet A.

Funct Neurol. 2000 Jan-Mar;15(1):35-40.

PMID:
10842758
8.

[Course of peripheral diabetic neuropathy depending on the metabolic control after 6 months of follow-up].

Pérez-Lázaro A, Ascaso JF, Chapa MA, Hernández A, Catalá M, Carmena R.

Med Clin (Barc). 1990 May 12;94(18):693-6. Spanish.

PMID:
2388494
9.

Early detection of diabetic neuropathy: a neurophysiological study on 100 patients.

Braune HJ.

Electromyogr Clin Neurophysiol. 1997 Oct;37(7):399-407.

PMID:
9402428
10.

VEGF gene transfer for diabetic neuropathy.

Isner JM, Ropper A, Hirst K.

Hum Gene Ther. 2001 Aug 10;12(12):1593-4.

PMID:
11529248
11.

Sensory nerve conduction in diabetes mellitus and diabetic neuropathy.

Sathiamoorthy A, Reddy LP, Sathiamoorthy SS, Balachander J, Chandrasekar S.

Indian J Physiol Pharmacol. 1983 Apr-Jun;27(2):118-22.

PMID:
6885123
12.

Effect of gangliosides on diabetic peripheral neuropathy.

Liniger C, Pernet A, Moody JF, Assal JP.

Diabetes Res Clin Pract. 1989 Nov 6;7(4):251-8.

PMID:
2693027
13.

[Study of the onset and progression of peripheral neuropathy and hypertension in NIDDM].

Jarmuzewska EA, Ghidoni A.

Minerva Med. 2000 Jan-Feb;91(1-2):1-15. Italian.

PMID:
10858728
14.

Diabetic peripheral neuropathy: effects of age, duration of diabetes, glycemic control, and vascular factors.

Valensi P, Giroux C, Seeboth-Ghalayini B, Attali JR.

J Diabetes Complications. 1997 Jan-Feb;11(1):27-34.

PMID:
9025010
15.
16.
17.

Endothelial and neural regulation of skin microvascular blood flow in patients with diabetic peripheral neuropathy: effect of treatment with the isoform-specific protein kinase C beta inhibitor, ruboxistaurin.

Brooks B, Delaney-Robinson C, Molyneaux L, Yue DK.

J Diabetes Complications. 2008 Mar-Apr;22(2):88-95. doi: 10.1016/j.jdiacomp.2007.07.002.

PMID:
18280438
18.

A comparison of sural nerve conduction studies in patients with impaired oral glucose tolerance test.

Koçer A, Domaç FM, Boylu E, Us O, Tanridağ T.

Acta Neurol Scand. 2007 Dec;116(6):399-405.

PMID:
17986099
19.
20.

C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy.

Ekberg K, Brismar T, Johansson BL, Lindström P, Juntti-Berggren L, Norrby A, Berne C, Arnqvist HJ, Bolinder J, Wahren J.

Diabetes Care. 2007 Jan;30(1):71-6.

PMID:
17192336

Supplemental Content

Support Center